title: The treatment outcome for adult patients with Ewing's sarcoma.
abstract: Ewing's sarcoma is the second most common bone malignancy in children, but is extremely rare in adults. The outcome of patients with localized disease has improved over the past decades due to better combination chemotherapies, and better methods of local control. Unfortunately, patients with metastatic disease have a very poor outcome with current antineoplastic therapies. In this article, we will review the primary treatment for adult patients with Ewing's sarcoma, both for localized and metastatic disease. The prognostic factors in adult patients with EWS will also be reviewed.
authors.affiliation: Department of Medicine, Division of Oncology, Stanford Comprehensive Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA. kganjoo@stanford.edu
authors.forename: Kristen N
authors.initials: KN
authors.lastname: Ganjoo
authors.forename: Shreyaskumar
authors.initials: S
authors.lastname: Patel
mesh_terms: D000328:Adult; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D012512:Sarcoma, Ewing / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents